Average Co-Inventor Count = 12.05
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (16 from 2,405 patents)
2. Merck Canada Inc. (5 from 40 patents)
3. Msd R&d (china) Co., Ltd. (1 from 10 patents)
4. Msd R&d Co., Ltd. (0 patent)
16 patents:
1. 12344595 - 2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
2. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
3. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors
4. 11802122 - 2-oxoimidazolidine-4-carboxamides as NA1.8 inhibitors
5. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors
6. 10138255 - Piperazine derivatives as HIV protease inhibitors
7. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
8. 9994587 - HIV protease inhibitors
9. 9840478 - Piperazine derivatives as HIV protease inhibitors
10. 9834526 - HIV protease inhibitors
11. 9737545 - HIV protease inhibitors
12. 9663506 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
13. 9636337 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
14. 9315475 - HIV protease inhibitors
15. 9278960 - Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use